{
    "title": "Moderna sees up to $4 billion in 2023 sales from private market for COVID shots",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12369981/Moderna-sees-4-billion-2023-sales-private-market-COVID-shots.html",
    "date": "2023-08-03",
    "keywords": [
        "vaccine",
        "market",
        "moderna",
        "year",
        "quarter",
        "shot",
        "price",
        "flu",
        "company",
        "leo",
        "wingrove",
        "forecast",
        "revenue",
        "government",
        "demand",
        "pfizer",
        "fall",
        "rsv",
        "estimate",
        "research",
        "development",
        "analyst",
        "loss",
        "aug",
        "inc",
        "covid19",
        "maker",
        "autumn",
        "vaccination",
        "campaign",
        "xbb15",
        "omicron",
        "subvariant",
        "coronavirus",
        "health",
        "season",
        "size",
        "time",
        "disease",
        "burden",
        "officer",
        "arpa",
        "garay",
        "conference",
        "call",
        "height",
        "march",
        "covid",
        "range",
        "afternoon",
        "trading",
        "companys",
        "mani",
        "foroohar",
        "cash",
        "setup",
        "risk",
        "amp",
        "side",
        "rna",
        "technology",
        "phase",
        "event",
        "rest",
        "pipeline",
        "track",
        "td",
        "cowen",
        "tyler",
        "van",
        "buren",
        "launch",
        "product",
        "anticipation",
        "approval",
        "share",
        "reporting",
        "bengaluru",
        "york",
        "editing",
        "shinjini",
        "ganguli",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}